Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
出版年份 2014 全文链接
标题
Amyloid-based immunotherapy for Alzheimer's disease in the time of prevention trials: the way forward
作者
关键词
-
出版物
Expert Review of Clinical Immunology
Volume 10, Issue 3, Pages 405-419
出版商
Informa UK Limited
发表日期
2014-02-04
DOI
10.1586/1744666x.2014.883921
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Anti-Amyloid-β Immunotherapy in Alzheimer's Disease: ACC-001 Clinical Trials Are Ongoing
- (2017) J. Michael Ryan et al. JOURNAL OF ALZHEIMERS DISEASE
- 2013 Alzheimer's disease facts and figures
- (2013) Alzheimers & Dementia
- Immunotherapy in Alzheimer’s Disease: Do We Have All the Pieces of the Puzzle?
- (2013) Marie Sarazin et al. BIOLOGICAL PSYCHIATRY
- CR1 and the “Vanishing Amyloid” Hypothesis of Alzheimer’s Disease
- (2013) Sam Gandy et al. BIOLOGICAL PSYCHIATRY
- Safety and Pharmacology of Ponezumab (PF-04360365) After a Single 10-Minute Intravenous Infusion in Subjects With Mild to Moderate Alzheimer Disease
- (2013) Aaron H. Burstein et al. CLINICAL NEUROPHARMACOLOGY
- Safety and Pharmacology of a Single Intravenous Dose of Ponezumab in Subjects With Mild-to-Moderate Alzheimer Disease
- (2013) Jaren W. Landen et al. CLINICAL NEUROPHARMACOLOGY
- Immunotherapy for Targeting Tau Pathology in Alzheimer’s Disease and Tauopathies
- (2013) Hanna Rosenmann Current Alzheimer Research
- Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
- (2013) Lea Rozenstein-Tsalkovich et al. EXPERIMENTAL NEUROLOGY
- Bapineuzumab and solanezumab for Alzheimer's disease: is the ‘amyloid cascade hypothesis' still alive?
- (2013) Haythum O Tayeb et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Clinical trials of amyloid-based immunotherapy for Alzheimer's disease: end of beginning or beginning of end?
- (2013) Yun Li et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Intravenous immunoglobulin and Alzheimer’s disease: what now?
- (2013) David A Loeffler Journal of Neuroinflammation
- Immunogenicity, Efficacy, Safety, and Mechanism of Action of Epitope Vaccine (Lu AF20513) for Alzheimer's Disease: Prelude to a Clinical Trial
- (2013) H. Davtyan et al. JOURNAL OF NEUROSCIENCE
- Intravenous immunoglobulin for treatment of mild-to-moderate Alzheimer's disease: a phase 2, randomised, double-blind, placebo-controlled, dose-finding trial
- (2013) Richard Dodel et al. LANCET NEUROLOGY
- Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
- (2013) Victor L Villemagne et al. LANCET NEUROLOGY
- Immunotherapy for Alzheimer’s disease: hoops and hurdles
- (2013) Cynthia A Lemere Molecular Neurodegeneration
- Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
- (2013) Ana Griciuc et al. NEURON
- Development of a New DNA Vaccine for Alzheimer Disease Targeting a Wide Range of Aβ Species and Amyloidogenic Peptides
- (2013) Yoh Matsumoto et al. PLoS One
- Passive anti-amyloid immunotherapy in Alzheimer's disease: What are the most promising targets?
- (2013) Jens Moreth et al. Immunity & Ageing
- Safety and biomarker effects of solanezumab in patients with Alzheimer’s disease
- (2012) Martin Farlow et al. Alzheimers & Dementia
- Effect of Immunotherapy With Bapineuzumab on Cerebrospinal Fluid Biomarker Levels in Patients With Mild to Moderate Alzheimer Disease
- (2012) Henrik Zetterberg ARCHIVES OF NEUROLOGY
- Effect of Complement CR1 on Brain Amyloid Burden During Aging and Its Modification by APOE Genotype
- (2012) Madhav Thambisetty et al. BIOLOGICAL PSYCHIATRY
- AICD Nuclear Signaling and Its Possible Contribution to Alzheimers Disease
- (2012) Uwe Konietzko Current Alzheimer Research
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Gantenerumab for the treatment of Alzheimer's disease
- (2012) Julien Delrieu et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Solanezumab for the treatment of mild-to-moderate Alzheimer’s disease
- (2012) Bruno P Imbimbo et al. Expert Review of Clinical Immunology
- New and emerging treatments for Alzheimer’s disease
- (2012) Anne Corbett et al. Expert Review of Neurotherapeutics
- Immunotherapy for Alzheimer’s disease: from anti-β-amyloid to tau-based immunization strategies
- (2012) Francesco Panza et al. Immunotherapy
- Anti-apoE immunotherapy inhibits amyloid accumulation in a transgenic mouse model of Aβ amyloidosis
- (2012) Jungsu Kim et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intranasal inoculation with an adenovirus vaccine encoding ten repeats of Aβ3-10 reduces AD-like pathology and cognitive impairment in Tg-APPswe/PSEN1dE9 mice
- (2012) Yu Li et al. JOURNAL OF NEUROIMMUNOLOGY
- Therapeutic strategies for tau mediated neurodegeneration
- (2012) Y. Yoshiyama et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- An Effector-Reduced Anti- -Amyloid (A ) Antibody with Unique A Binding Properties Promotes Neuroprotection and Glial Engulfment of A
- (2012) O. Adolfsson et al. JOURNAL OF NEUROSCIENCE
- Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study
- (2012) Bengt Winblad et al. LANCET NEUROLOGY
- Active vaccination with ankyrin G reduces β-amyloid pathology in APP transgenic mice
- (2012) A C Santuccione et al. MOLECULAR PSYCHIATRY
- Genentech's Alzheimer's antibody trial to study disease prevention
- (2012) Ken Garber NATURE BIOTECHNOLOGY
- Immunization targeting a minor plaque constituent clears β-amyloid and rescues behavioral deficits in an Alzheimer's disease mouse model
- (2012) Jose Morales-Corraliza et al. NEUROBIOLOGY OF AGING
- Passive Immunization against Pyroglutamate-3 Amyloid-ß Reduces Plaque Burden in Alzheimer-Like Transgenic Mice: A Pilot Study
- (2012) Jeffrey L. Frost et al. Neurodegenerative Diseases
- A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice
- (2012) Ronald B. DeMattos et al. NEURON
- Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
- (2012) Randall J. Bateman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Variant TREM2 as Risk Factor for Alzheimer's Disease
- (2012) Harald Neumann et al. NEW ENGLAND JOURNAL OF MEDICINE
- Stopping Alzheimer's Before It Starts
- (2012) G. Miller SCIENCE
- Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: Recommendations from the Alzheimer’s Association Research Roundtable Workgroup
- (2011) Reisa A. Sperling et al. Alzheimers & Dementia
- The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Guy M. McKhann et al. Alzheimers & Dementia
- The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer's disease
- (2011) Marilyn S. Albert et al. Alzheimers & Dementia
- Mechanism of Amyloid Removal in Patients With Alzheimer Disease Treated With Gantenerumab
- (2011) Susanne Ostrowitzki ARCHIVES OF NEUROLOGY
- Nuclear signalling by membrane protein intracellular domains: The AICD enigma
- (2011) Caroline Beckett et al. CELLULAR SIGNALLING
- Anti-β-Amyloid Immunotherapy for Alzheimers Disease: Focus on Bapineuzumab
- (2011) Francesco Panza et al. Current Alzheimer Research
- Antibody-based therapy in Alzheimer's disease
- (2011) Refik Pul et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Passive Immunization with Anti-Tau Antibodies in Two Transgenic Models
- (2011) Xiyun Chai et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- The physiology of the β-amyloid precursor protein intracellular domain AICD
- (2011) Raphaëlle Pardossi-Piquard et al. JOURNAL OF NEUROCHEMISTRY
- The Second-Generation Active A Immunotherapy CAD106 Reduces Amyloid Accumulation in APP Transgenic Mice While Minimizing Potential Side Effects
- (2011) C. Wiessner et al. JOURNAL OF NEUROSCIENCE
- Tau-Targeted Immunization Impedes Progression of Neurofibrillary Histopathology in Aged P301L Tau Transgenic Mice
- (2011) Mian Bi et al. PLoS One
- Effect of rice-expressed amyloid β in the Tg2576 Alzheimer's disease transgenic mouse model
- (2011) Jun Nojima et al. VACCINE
- The presence of sodium dodecyl sulphate-stable Aβ dimers is strongly associated with Alzheimer-type dementia
- (2010) Jessica M. Mc Donald et al. BRAIN
- Safety and Changes in Plasma and Cerebrospinal Fluid Amyloid β After a Single Administration of an Amyloid β Monoclonal Antibody in Subjects With Alzheimer Disease
- (2010) Eric R. Siemers et al. CLINICAL NEUROPHARMACOLOGY
- TAU Aggregation is a Therapeutic Target for Alzheimers Disease
- (2010) A. Takashima Current Alzheimer Research
- Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
- (2010) Moran Boimel et al. EXPERIMENTAL NEUROLOGY
- The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway
- (2010) Nikolai D. Belyaev et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease
- (2010) Johanna Magga et al. Journal of Neuroinflammation
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
- Revising the definition of Alzheimer's disease: a new lexicon
- (2010) Bruno Dubois et al. LANCET NEUROLOGY
- 11C-PiB PET assessment of change in fibrillar amyloid-β load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo-controlled, ascending-dose study
- (2010) Juha O Rinne et al. LANCET NEUROLOGY
- Alzheimer's disease: clinical trials and drug development
- (2010) Francesca Mangialasche et al. LANCET NEUROLOGY
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- β-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain
- (2010) Erica Buoso et al. PHARMACOLOGICAL RESEARCH
- APP Intracellular Domain Impairs Adult Neurogenesis in Transgenic Mice by Inducing Neuroinflammation
- (2010) Kaushik Ghosal et al. PLoS One
- Decreased Clearance of CNS -Amyloid in Alzheimer's Disease
- (2010) K. G. Mawuenyega et al. SCIENCE
- Mechanisms of tau-induced neurodegeneration
- (2009) Khalid Iqbal et al. ACTA NEUROPATHOLOGICA
- Tau vaccine: Active immunization with misfolded tau protein attenuates tau pathology in the transgenic rat model of tauopathy
- (2009) Michal Novak Alzheimers & Dementia
- Long-Term Follow-Up of Patients Immunized with AN1792: Reduced Functional Decline in Antibody Responders
- (2009) Bruno Vellas et al. Current Alzheimer Research
- Disease-Modifying Approach to the Treatment of Alzheimerʼs Disease
- (2009) Francesco Panza et al. DRUGS & AGING
- Nuclear signaling by the APP intracellular domain occurs predominantly through the amyloidogenic processing pathway
- (2009) Z. V. Goodger et al. JOURNAL OF CELL SCIENCE
- Vaccination with A -Displaying Virus-Like Particles Reduces Soluble and Insoluble Cerebral A and Lowers Plaque Burden in APP Transgenic Mice
- (2009) P. Bach et al. JOURNAL OF IMMUNOLOGY
- A Immunotherapy: Intracerebral Sequestration of A by an Anti-A Monoclonal Antibody 266 with High Affinity to Soluble A
- (2009) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- Development of AFFITOPE vaccines for Alzheimer’s disease (AD) — From concept to clinical testing
- (2009) A. Schneeberger et al. Journal of Nutrition Health & Aging
- Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies
- (2009) Kurt R. Brunden et al. NATURE REVIEWS DRUG DISCOVERY
- A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease
- (2009) S. Salloway et al. NEUROLOGY
- Oligomeric amyloid associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques
- (2009) R. M. Koffie et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Alzheimer's disease-like pathological features in transgenic mice expressing the APP intracellular domain
- (2009) K. Ghosal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- DNA epitope vaccine containing complement component C3d enhances anti-amyloid-β antibody production and polarizes the immune response towards a Th2 phenotype
- (2008) Nina Movsesyan et al. JOURNAL OF NEUROIMMUNOLOGY
- Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
- (2008) Clive Holmes et al. LANCET
- Amyloid-β protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory
- (2008) Ganesh M Shankar et al. NATURE MEDICINE
- Antibody Capture of Soluble Aβ Does Not Reduce Cortical Aβ Amyloidosis in the PDAPP Mouse
- (2008) Peter Seubert et al. Neurodegenerative Diseases
- Reducing AD-Like Pathology in 3xTg-AD Mouse Model by DNA Epitope Vaccine — A Novel Immunotherapeutic Strategy
- (2008) Nina Movsesyan et al. PLoS One
- The amyloid precursor protein intracellular domain (AICD) as modulator of gene expression, apoptosis, and cytoskeletal dynamics—Relevance for Alzheimer's disease
- (2008) Thorsten Müller et al. PROGRESS IN NEUROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now